In the article titled “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac” [1], there was an error in reference [24] where it should be replaced with the article titled “A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis” [2].
References
- 1.Walker C. Are all oral COX-2 selective inhibitors the same? a consideration of celecoxib, etoricoxib, and diclofenac. International Journal of Rheumatology. 2018;2018:12. doi: 10.1155/2018/1302835.1302835 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Matsumoto A. K., Melian A., Mandel D. R., et al. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. Journal of Rheumatology. 2002;29(8):1623–1630. [PubMed] [Google Scholar]